Video: Texas Children's Faris D. Virani Ewing Sarcoma Center Q&A

October 27, 2014


ewing sarcoma Texas Children’s Cancer Center has a first-of-its-kind center dedicated to perform state-of-the-art basic, translational and clinical research as well as provide the best care and management for patients diagnosed with Ewing sarcoma.  The Faris D. Virani Ewing Sarcoma Center was established in February 2014 through the vision and generosity of Dr. Asha and Mr. Farid Virani in honor of their son Faris Deedar Virani, who was diagnosed and is being treated for Ewing sarcoma. While rare, Ewing sarcoma is the second most common bone tumor in the pediatric population. It is often a very aggressive cancer that most frequently affects the hip, legs, chest and arms. In the United States approximately 250 children are diagnosed with Ewing sarcoma each year. Texas Children’s alone receives approximately 8-12 new diagnoses of Ewing sarcoma each year. In addition to treating patients with Ewing sarcoma, the center also has a strong emphasis on research. We firmly believe that the breakthrough discoveries that take place in the laboratories of the center will exemplify the future of Ewing sarcoma treatment and the best hope for children with this disease. To learn more about Texas Children’s Faris D. Virani Ewing Sarcoma Center, watch the Q&A video below or visit our website.

Post by:

Jason T. Yustein, MD, PhD

Dr. Jason Yustein is Director of the Faris D. Virani Ewing Sarcoma Center and a member of the Bone Tumors Program. His clinical interests are focused on pediatric sarcomas, such as Ewing sarcoma.

Dr. Yustein is one of the experts participating in the New Agents for Ewing Sarcoma Task...

Read More